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KAJIAN TERHADAP KEANTIGENAN 
Salmonella enterica subspecies enterica serovar Typhi  
50 KDa PROTEIN REKOMBINAN 
 
ABSTRAK 
Protein membran luar (OMP) 50 kDa Salmonella Typhi dilaporkan antigenik dan 
telah digunakan untuk membuat kit Typhidot® yang berjaya dikomersilkan. Walau 
bagaimanapun spesifikasi Typhidot® mempunyai julat variasi antara 37.5 - 98.8%. Ini 
mungkin disebabkan oleh pencemaran protein lain semasa penyediaan protein membran luar 
50 kDa dan ianya mungkin telah menjejaskan spesifikasi OMP 50 kDa. Oleh itu, objektif 
kajian adalah untuk menyiasat identiti protein individu yang terkandung kompleks OMP 50 
kDa untuk menentukan protein immunodominant yang bertanggungjawab terhadap 
keantigenannya dan meningkatkan sensitiviti dan spesifikasi ujian Typhidot®. Gel 
elektroforesis 2-D dan LC-MS / MS telah digunakan untuk identifikasi protein yang 
terkandung dalam OMP 50 kDa.  Daripada protein yang telah dikenal pasti, protein TolC, 
GlpK dan SucB telah dipilih sebagai protein antigenik yang berpotensi dalam 50 kDa OMP 
dan protein rekombinan telah dihasilkan dalam E. coli. Oleh disebabkan oleh sifat protein 
yang tidak larut, proses penulenan protein telah dilakukan dengan menggunakan keadaan asli 
dan kenyahaslian untuk meningkatkan hasil protein yang larut. Keputusan ELISA telah 
menunjukkan bahawa protein rekombinan GlpK (rGlpK) dan protein rekombinan FliC (rFliC) 
bertindakbalas terhadap serum tifoid yang dikumpulkan bersama telah menunjukkan bacaan 
penyerapan ELISA yang tertinggi. Sedangkan protein rekombinan TolC (rTolC) dan protein 
rekombinan SucB (rSucB) menunjukkan bacaan penyerapan ELISA yang rendah. Didapati 
bahawa antibodi bertindak balas dengan lebih kuat dengan protein rGlpK dan rFliC yang 
ditulenkan di bawah keadaan asli. Ini mencadangkan kehadiran epitope linear dan 
berkonformasi pada protein ini. Walau bagaimanapun kedua-dua protein ini tidak sesuai 
untuk digunakan sebagai biopenanda kerana kedua-dua protein bergabung dengan tidak 
spesifik dengan antibodi yang berkandung dalam serum normal dan protein rFliC akan 
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bertindak balas dengan antibodi dalam sera pesakit dijangkiti oleh serovar Salmonella lain 
dan organisma yang bukan Salmonella.  Antigen rSucB mempunyai afiniti pengikatan yang 
rendah dengan sera tifoid yang dikumpulkan bersama, oleh itu, ianya tidak sesuai digunakan 
sebagai biopenanda. Walaupun skor prediksi antigeniti yang tinggi untuk TolC, TolC 
didapati sebagai antigen yang lemah untuk mengesan antibodi tifoid oleh ELISA. Ini 
disebabkan oleh antigen rTolC yang diekspresi dalam sistem expresi E. coli kurang larut. 
Sistem ekspresi hos S. Typhi digunakan untuk meningkatkan kelarutan TolC. Keantigenan 
TolC yang diekspreskan dalam dua sistem ekspresi yang berbeza telah dinilai menggunakan 
ELISA. Keputusan menunjukkan bahawa keantigenan protein TolC yang diekspresi dalam S. 
Typhi (rTyTolC) jauh lebih tinggi daripada rTolC yang diekspresi dalam E. coli. (rEcTolC). 
Oleh itu, antigen rTyTolC dipilih untuk pembangunan immunoassay dalam tiga platform 
teknologi yang berbeza iaitu dot enzyme immunoassay (DotEIA), ELISA dan lateral flow. 
rTyTolC didapati mampu mengesan ketiga-tiga subkelas antibodi (IgM, IgG and IgA) yang 
berguna untuk membezakan pelbagai peringkat jangkitan tifoid. Keputusan sensitiviti dan 
spesifikasi untuk rTyTolC-DotEIA adalah seperti  berikut: 67.5% dan 90.0% untuk rTyTolC-
DotEIA-IgM, 94.5% dan 53.3% untuk rTyTolC-DotEIA-IgG, 97.3% dan 90.0% untuk 
rTyTolC-DotEIA-IgA. Keputusan sensitiviti dan spesifikasi untuk rTyTolC-ELISA adalah 
seperti  berikut: 32.4% 96.6% untuk rTyTolC-ELISA-IgM, 64.8% dan 96.0% untuk 
rTyTolC-ELISA-IgG, 78.0% dan 93.3% untuk rTyTolC-ELISA-IgA. Lateral Flow didapati 
sebagai pilihan terbaik di antara tiga platform yang berbeza. Keputusan sensitiviti dan 
spesifikasi untuk rTyTolC-LF adalah seperti  berikut: 100.0% untuk rTyTolC-LF-IgG dan 
100.0% dan 90.0% untuk rTyTolC-LF-IgA. Ini menunjukkan kegunaan antigen rTyTolC 
dalam setiap ujian (DotEIA, ELISA dan aliran lateral) untuk diagnosis demam kepialu. 
Berbanding dengan OMP 50 kDa, protein rTyTolC adalah antigen alternatif yang lebih baik 
untuk diagnosis deman kepialu.  
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A STUDY OF THE ANTIGENICITY OF  
Salmonella enterica subspecies enterica serovar 
 Typhi 50 KDa RECOMBINANT PROTEINS 
 
ABSTRACT 
S. Typhi 50 kDa outer-membrane protein (OMP) was reported to be antigenic and 
has been used to develop the commercially successful Typhidot® kit. However, the 
specificity of the kit varies from 37.5 to 98.8%. This might be due to contamination with 
other proteins during the 50 kDa OMP preparation and it could have affected the specificity 
of the 50 kDa OMP. The objective of this study was to investigate the identities of the 
individual proteins contained in the 50 kDa protein complex to pinpoint the 
immunodominant protein(s) responsible for its antigenicity, and thus improve the sensitivity 
and specificity of the Typhidot® test. 2D-gel electrophoresis and LC-MS/MS were used to 
identify the proteins in the complex. From the pool of identified proteins, TolC, GlpK, FliC 
and SucB were identified as potential antigenic proteins in the 50 kDa OMP complex and 
recombinant proteins were produced in E. coli. Due to the insoluble nature of the proteins, 
purification was carried out using native and denaturing conditions to improve the yield of 
soluble recombinant proteins. The ELISA results showed that recombinant GlpK (rGlpK) 
and recombinant FliC (rFliC) against pooled typhoid sera have the highest absorbance 
reading, while recombinant TolC (rTolC) and recombinant SucB (rSucB) showed low 
absorbance reading. The ELISA results also showed that the antibodies reacted stronger with 
the rGlpK and rFliC proteins when there were purified under native condition. This 
suggested the presence of linear and conformational epitopes on these proteins. However 
these two proteins were found to be unsuitable as biomarkers due to non-specific binding 
with pooled normal serum and rFliC protein cross-reacted with antibodies in sera of subjects 
infected with other Salmonella and non-Salmonella serovars. The rSucB antigen had lower 
binding affinity with pooled typhoid sera and was not suitable to be used as a biomarker. 
Despite its high antigenicity prediction score, TolC was found to be a poor antigen (less 
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specific) for detection of typhoid antibodies by ELISA. This may be due to the rTolC antigen 
expressed in E. coli expression system lack solubility. A native S. Typhi host cell expression 
system was used to improve the solubility of the rTolC. The antigenicity of the rTolC 
expressed in the two different expression systems was evaluated using ELISA. The results 
showed that the antigenicity of the rTolC protein expressed in native S. Typhi (rTyTolC) was 
significantly higher than the rTolC expressed in E. coli (rEcTolC). Hence, the rTyTolC 
antigen was selected for immunoassay development in 3 different technological platforms: 
Dot Enzyme Immunoassay (DotEIA), ELISA and Lateral Flow formats. It was found that 
rTyTolC was able to detect different subclasses of antibody (IgM, IgG and IgA), which can 
be useful in differentiating the different stages of typhoid infection. The sensitivity and 
specificity of the rTyTolC DotEIA were as follows: 67.5% and 90.0% for rTyTolC-DotEIA-
IgM, 94.5% and 53.3% for rTyTolC-DotEIA-IgG, 97.3% and 90.0% for rTyTolC-DotEIA-
IgA. The sensitivity and specificity of the rTyTolC-ELISA were as follows: 32.4% and 96.6% 
for rTyTolC-ELISA-IgM, 64.8% and 96.0% for rTyTolC-ELISA-IgG, 78.0% and 93.3% for 
rTyTolC-ELISA-IgA. The Lateral Flow format was found to be the best among 3 different 
platforms. The sensitivity and specificity of the rTyTolC-LF were as follows: 100.0% and 
75.0% for rTyTolC-LF-IgM, 100.0% and 85.0% for rTyTolC-LF-IgG, and 100.0% and 90.0% 
for for rTyTolC-LF-IgA. This demonstrated the usefulness of rTyTolC antigen in each of the 
assays (DotEIA, ELISA and lateral flow) for the diagnosis of typhoid fever. In comparison 
with the 50 kDa OMP, the rTyTolC protein is a better alternative antigen for diagnosis of 
typhoid fever. 
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CHAPTER 1 
INTRODUCTION 
1.1 Research Background 
Typhoid fever still remains a major health problem in developing countries due to limitations 
of current diagnostic tests for the detection of S. Typhi infection. Rapid and accurate 
diagnosis is of crucial importance to ensure effective disease management and control. The 
lack of case detection hinders proper disease control and surveillance. If left untreated, 
typhoid fever patients can have dire consequences, such as intestinal perforation, septicaemia, 
chronic carrier state, and even death (Huang and DuPont, 2005).   
 
The current “gold standard” for typhoid fever diagnosis is the blood culture method. This 
method gives excellent specificity but has low sensitivity. In addition to that, it is time 
consuming, requiring 4 to 7 days to perform the test. Whereas for bone marrow culture, it 
has high sensitivity but is difficult to perform. Another method for diagnosis of typhoid fever 
is the stool culture method. This method had poor sensitivity during the acute phase of the 
infection but is important to monitor typhoid carriers as typhoid carriers shed the bacteria 
intermittently from the gall bladder into the stool (Akoh, 1991). All these methods requires 
technician with proper laboratory training and equipment. Many new rapid diagnostic tests 
have been developed but they lack sensitivity and specificity (Olsen et al., 2004). One of the 
reasons for lack of specificity is because S. Typhi antigen tends to cross-react with other 
Salmonella species. On top of that, S. Typhi and E. coli, another human pathogen, have 
similar sequence in genomic DNA.  Thus, antigen cross-reactivity tends to occur. Therefore, 
there is a need to develop more specific biomarkers for typhoid fever diagnosis.  
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Recent advancement in the field of molecular immunology has led to the identification of a 
new marker for typhoid fever which have good sensitivity and specificity. This allowed the 
development of more practical and inexpensive test kits for rapid diagnosis of typhoid fever. 
Example of a current rapid test for detection of typhoid fever in the market today is 
Typhidot®. Typhidot® utilizes a S. Typhi specific antigenic, 50 kDa outer membrane 
protein  (OMP) of S. Typhi to detect the presence of anti-50 kDa antibodies of IgG and IgM 
isotypes (Ismail et al., 1991b). Typhidot has a reported sensitivity greater than 90% with 75% 
specificity (Choo et al., 1994). A derivative of the Typhidot is the Typhidot-M, which 
exclusively detects the presence of anti-50 kDa IgM antibody with a sensitivity and 
specificity of 92% and 100% respectively. 
 
Further development based on the 50 kDa OMP lead to the development of a Dot blot that 
was used for screening of typhoid carriers. The screening for typhoid carriers was conducted 
on food handlers. The Dot blot test was designed based on the immunological response of 
the patient against the 50 kDa OMP complex. The test detects the presence of anti-50 kDa 
OMP complex antibodies of the IgA and IgG isotypes in the serum of suspected carriers 
(Chua et al., 2015). Specific IgA antibodies serves as a marker for typhoid carriers as anti-S 
Typhi IgA antibodies are known to be elevated during the first few weeks of acute typhoid 
infection and resides significantly afterward.   
 
The original work of the 50 kDa OMP complex was carried out using SDS-PAGE and 
Western blot analysis, and revealed the presence of a 50 kDa specific antigenic protein on 
the outer membrane of S. Typhi (Ismail et al., 1991b). During the preparation of the 50 kDa 
OMP, the 50 kDa band was eluted out from the polyacrylamide gel by electroelution. The 50 
kDa OMP was used to produce the Typhidot® kit. This kit had been marketed worldwide 
and considered as the test of choice for typhoid fever due to its high sensitivity and 
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specificity. However, recent reports have suggested that the kit lacks specificity, with 
specificity ranges from 37.5 to 98.8% (Narayanappa et al., 2010; Mehmood et al., 2015; 
Olsen et al., 2004; Membrebe, 1999). Therefore, the suitability of the 50 kDa OMP as a 
diagnostic marker was questioned. Since only SDS-PAGE and Western blot were done, the 
possibility that the 50 kDa OMP might be a mixture of proteins that would contain other 
OMPs which migrated together to yield a band at the 50 kDa molecular weight. The 
presence of proteins co-purified together with the 50 kDa OMP could have affected the 
specificity of the 50 kDa OMP. Thus, it is important to investigate on the possibility of the 
50 kDa OMP being a single protein or a protein complex. In order to investigate on this, the 
50 kDa OMP was subjected to 2D-PAGE gel analysis and LC-MS/MS analysis to isolate and 
identify the proteins present in the 50 kDa band. By using 2D-PAGE, proteins with the same 
molecular weight but with different isoelectric points can be separated. LC-MS/MS can be 
used to identify all the proteins contained in the 50 kDa band. The identification of the other 
proteins in the 50 kDa protein complex possessed a significant question to the application of 
the 50 kDa OMP as the antigen of the Typhidot diagnostic kit. The antigenicity, specificity 
and sensitivity of these proteins individually as a diagnostic biomarker for typhoid fever, 
have yet to be explored. The efficacy of these individual antigenic proteins have to be 
elucidated to allow further improvement and development of more sensitive and specific 
diagnostic tests for typhoid fever. 
 
Current production of the 50 kDa OMP from S. Typhi is time-consuming and tedious with a 
low protein yield. To overcome the current bottleneck of low yield for production of 
diagnostics, an E. coli recombinant protein expression system was used to overcome this. 
Producing recombinant proteins also ensure sufficient proteins for validation test. The 
production of recombinant antigens will be beneficial in reducing the cost of production of 
the antigen, which will result in lower cost of the test and making it more affordable. The 
production of recombinant Histidine-tagged proteins enables large-scale protein purification. 
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The purified proteins can then be purified easily using affinity-chromatography in sufficient 
quantities to study their specificity and sensitivity using ELISA. Thus, the focus of the next 
part of this thesis was on cloning and purifying each selected proteins in the 50 kDa complex 
of S. Typhi for the development of protein-based diagnostics.  
 
Previous studies have shown that OMPs of S. Typhi were mostly expressed as inclusion 
bodies or insoluble form in E. coli recombinant expression system (Jindal et al., 2012). 
OMPs are known to have low protein solubility when expressed as recombinant proteins due 
to their hydrophobicity. In addition, the proteins expressed might vary between different 
hosts due to different protein folding tendencies. To overcome the problem of OMP being 
expressed as inclusion bodies, a native host expression system was selected to produce these 
proteins for comparison with the recombinant E. coli system. The host cells used was S. 
Typhi Ty21a, a strain commonly used for vaccination. The use of Ty21a would allow the 
homologous expression of the proteins in the native form. The expression of recombinant 
proteins in its native form would allow the expression and folding of the protein to be the 
same as the proteins from S. Typhi, where the 50 kDa OMP was extracted. This will lower 
the possibility of the recombinant OMP expressed as inclusion bodies. The gene of each 
individual protein was cloned in an expression plasmid with his-tag to allow easy 
purification. These systems were then compared with the recombinant plasmid expressing 
his-tag proteins in E. coli and S. Typhi host for production of recombinant proteins.  
 
The final part of this study involved the selection of the best recombinant protein candidate 
to use as protein-based rapid diagnostics on DotEIA, ELISA and lateral flow platforms. Each 
platform has its own benefits. The sensitivity and specificity of each of the assays were 
evaluated. DotEIA test offers cheap and simple test suitable for resource-limited countries. 
ELISA provides a diagnostic platform that has higher sensitivity to determine antibody 
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present in small samples. Due to automation capabilities, ELISA enables processing of large 
quantities of samples in a single run. Principle of both DotEIA and ELISA tests is as shown 
in Figure 1.1. While for lateral flow platform, an immunochromatography test, is based on 
detection of antibodies present in the blood of typhoid patient. Principle of lateral flow assay 
is as shown in Figure 1.2. For lateral flow test, low cost tests can be produced quickly and 
can be easily shipped without cold chain control. The lateral flow platform does not require 
highly trained professionals to perform the test. Lateral flow systems are easy to use without 
the need for any instrumentation and are ideal for POC applications. Thus, the antigenic 
proteins were evaluated using these technological platforms to evaluate the sensitivity and 
specificity of each platform for diagnosis of typhoid fever.  
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1.2 Objectives 
1.2.1 General Objective 
To identify and produce specific antigenic proteins of S. Typhi, for development of 
diagnostic tests for typhoid fever and/or carriers. 
1.2.2 Specific Objectives 
Identification of specific proteins  
1) To characterize the composition of the 50 kDa OMP complex of S. Typhi using 2D-PAGE 
and LC-MS/MS  
2) To construct and clone the identified specific protein(s) into an expression plasmid(s) for 
producing recombinant protein(s) for antigenicity studies. 
3) To optimize the conditions for the culture and expression of individual proteins identified 
for expression systems in E. coli and of S. Typhi host cells. 
4) To compare the antigenicity of the recombinant proteins expressed in E. coli and S. Typhi 
host cells. 
5) To purify the recombinant proteins via affinity chromatography. 
6) To evaluate the recombinant proteins‟ antigenicity using indirect ELISA. 
7) To develop and evaluate the protein-based diagnostics using the DotEIA, ELISA and LF 
platforms. 
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CHAPTER 2 
LITERATURE REVIEW 
2.1   Typhoid Fever 
Typhoid fever, also known as enteric fever, is a global health problem. This life-threatening 
illness is caused by the pathogenic bacteria name Salmonella enterica subspecies enterica 
serovar Typhi (S. Typhi). Salmonella is a member of the family Enterobactericeae. The 
Salmonella genus contains two species known as S. enterica and S. bongori. S. enterica can 
be further separated into six subspecies (S. enterica subsp. enterica, S. enterica subsp. 
salamae, S. enterica subsp. arizonae, S. enterica subsp. diarizonae, S. enterica subsp. 
houtenae and S. enterica subsp. indica). Most common serotypes of Salmonella that cause 
human infections are Enteritidis, Typhimurium, Newport and Javiana. Based on their 
serotype, pathogenic Salmonella bacteria are classified as either “typhoidal” or “non-
typhoidal”. Typhoid fever and paratyphoid fevers caused by typhoidal Salmonella include 
the serotypes Typhi, Paratyphi A, Paratyphi B and Paratyphi C. Non-typhoidial Salmonella 
refers to all other Salmonella serotypes that cause gastroenteriditis in human (Townes, 2010).  
 
S. Typhi is a Gram-negative, facultative anaerobic, non-encapsulated, flagellated bacilli with 
a diameter of 0.4 - 0.6 μm and a length of 2 - 3 μm (Crum, 2003). The life cycle of this 
bacterium generally involves colonization of the lumen of the intestine of human and 
animals, and transmission via the external environment occurs between hosts (Baker and 
Dougan, 2007). Symptoms of typhoid fever vary from mild illness with low-grade fever, 
malaise, and slight dry cough to a severe abdominal discomfort and multiple complications 
(WHO, 2003). Untreated, typhoid fever might progress to delirium, obtundation, intestinal 
hemorrhage, bowel perforation, and death within 1 month of contracting the disease. A less 
severe form of the disease is caused by the serotype Salmonella Paratyphi A, and the less 
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common serotypes by S. Paratyphi B and S. Paratyphi C (Crum, 2003). Other bacteria which 
are known to cause gastroenteritis enteric fever include Escherichia coli and Shigella species. 
 
Human is the only natural host for S. Typhi. The genome of S. Typhi comprises of 4.857-
kilobase (kb) pairs encoding around 4,000 genes, of which more than 200 are functionally 
inactive. Serological testing is commonly done for confirmation of the clinical isolate since 
the S. Typhi bacterium share common antigenic determinants with other Salmonella serovars. 
However, two key phenotypic feature of S. Typhi is the ability of the cell to colonizes the 
gall bladder serving as a reservoir for the further spread of the disease and the ability to 
invade the intestinal mucosa potentially through microfold (M) cells and establish an initially 
clinically undetectable infection as the pathogen does not trigger a rapid inflammatory or 
diarrheal response (Baker and Dougan, 2007). The virulence of S. Typhi is dependent on its 
ability to invade cells, possession of a complete lipopolysaccharide coat and presence of Vi 
antigen. However, there were cases of Vi-negative strains of S. Typhi that are able to cause 
the disease (Jegathesan, 1983). Analysis indicated that S. Typhi had seven of the 12 fimbrial-
like genes and several genes which are associated with the pathogenicity islands in the 
bacterial genome such as SPI-1, SPI-2, SPI-3, SPI-4 and SPI-5 have become inactivated 
when compare with non-typhoidal Salmonella serotypes (Townsend et al., 2001). 
Interestingly a few genes that are associated with intestinal attachment and persistence were 
inactivated in S. Typhi but not in S. Paratyphi (Baker and Dougan, 2007). Loss of function of 
these genes explained why S. Typhi invades the systemic tissues rather than confined to the 
luminal gut colonization. 
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2.2 Typhoid Fever Global Epidemiology 
Typhoid fever is a global health problem. It is found primarily in developing countries where 
sanitary conditions are poor. A study conducted in year 2000, estimated that typhoid fever 
caused 21.7 million illness and 217 thousand deaths globally (Crump et al., 2004). Countries 
endemic for typhoid fever include Asia, Africa, Latin America, the Caribbean, and Oceania. 
However, 80% of the cases were from Bangladesh, China, India, Indonesia, Laos, Nepal, 
Pakistan and Vietnam (Chau et al., 2007), where low socio-economic conditions prevail. The 
reason for this is because low socio-economic conditions are linked to poor access to clean 
water and good sanitation but a lack of laboratory diagnostics and health infrastructures 
contribute to the persistence of the disease. Cases that occur in developed countries are 
usually due to travelers who were infected outside of their native country. With proper 
antibiotic therapy, case fatality rates of patients suffering from typhoid fever is less than 1% 
and patients usually recover with a median of 6 days of hospitalization. If left untreated, 
typhoid fever is life-threatening with a fatality rate of approximately 15%. High risk regions 
such as South-Central Asia, Southeast Asia and southern Africa, have more than 100 
incident cases per 100,000 persons in the population each year. Medium risk regions include 
Asia, Africa, Latin America, and Oceania where 10 to 100 cases occur per 100,000 persons. 
The rest of the world including Australia and New Zealand and other developed countries 
are classified as low risk with less than 10 persons infected per 100,000 persons per year 
(Figure 2.1). S. Typhi infects humans of all age groups. However, higher number of cases are 
reported in children and young adults compared to the adults (Figure 2.2). 
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Figure 2.1: Geographical distribution of typhoid fever (Crump et al., 2004) 
 
Figure 2.2: Distribution of typhoid fever by age groups at high, medium and low incidence 
levels (Crump et al., 2004)  
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2.2.1 Typhoid Fever Epidemiology in Malaysia 
Malaysia was mapped as a region with high typhoid incidence rate with more than 100 cases 
per 100,000 population (Crump et al., 2004). The state of Kelantan in North Eastern 
Peninsular Malaysia is an endemic region for typhoid fever. Annual incidences of typhoid in 
Malaysia were 10.2 – 17.9 cases per 100,000 population and can reach as high as 50.3 cases 
per 100,000 in the state of Kelantan (Yap and Puthucheary, 1998). In Malaysia, Kelantan has 
the highest number of cases followed by Sabah, Terengganu, Selangor and Sarawak (Malik 
and Malik, 2001). A study was done to link the typhoid incidence to its distribution in 
Kelantan. High incidences in Kelantan are due to majority of the Kelantan people from rural 
areas who do not have access to safe water from treated water supplies and uses water from 
well for drinking and domestic purposes. In addition to that, the state of Kelantan was 
constantly hit by flooding. Incidence of typhoid spiked to its highest in 2005 (Figure 2.3) 
might be due to floods at the end of 2004 where flood waters overflowed into wells and 
contaminating them with S. Typhi. The study also concluded that there were no statistically 
significant association between ethnic group and typhoid fever (Safian N. et al., 2008). In 
endemic areas, the majority of the patients were children in the age group of 1 – 19 years 
(Ja'afar N. et al., 2013). Another study reported that the average age incidence of typhoid 
fever patients admitted to Hospital Universiti Sains Malaysia (HUSM) was 7.3 years (Choo 
et al., 1988).  
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Figure 2.3: Incidence rate of food and waterborne diseases per 100,000 population in 
Malaysia (1999 – 2009) (Ministry of Health Malaysia, 2009) 
 
2.3 Transmission of Typhoid Fever 
Humans are the only natural host and reservoir for S. Typhi. This bacterium is known to 
survive for long periods of time in ground water, pond water, or sea water, and for months in 
contaminated eggs and frozen oysters (Cho and Kim, 1999; Swaddiwudhipong and 
Kanlayanaphotporn, 2001; Nishio et al., 1981; Elsarnagawy, 1978). Shellfish from 
contaminated water and raw fruits and vegetable fertilized with human faeces have been the 
source of past outbreaks of typhoid fever. The highest incidence of typhoid outbreak 
happened when the water supply to large populations is contaminated with faeces. The 
infection dose of Salmonella is determined to be 1000 to 1 million bacilli when 
administrated orally to healthy individual (Levine et al., 2001; Hornick et al., 1970). The 
incubation period of typhoid fever is influenced by the size of the inoculum and how the 
organism was ingested. Primary mode of transmission is through fecal-oral route, which is 
through ingestion of faeces-contaminated water and food often by asymptomatic individuals 
or carrier, who chronically sheds the bacteria in places where typhoid fever is endemic. It 
also can be transmitted via hand to mouth during use of contaminated toilet and neglect of 
hand hygiene. There are also documented cases of typhoid fever, which are transmitted by 
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means of oral and anal sex (Reller et al., 2003). Other person-to-person transmission of 
Salmonella has been known to occur between infected individuals and their caregivers such 
as nurseries and welfare homes for the elderly. With proper sanitation and good personal 
hygiene such as consistent hand washing, boiling water and properly cooked food, can 
prevent the transmission of Salmonella. 
 
2.4 Diagnosis of Typhoid Fever 
In endemic regions, diagnosis tests are important to detect acute cases for clinical 
management, to detect convalescent and chronic fecal carriages for contact tracing and the 
measurement of acute and convalescent cases for assessment of disease burden. Diagnosis of 
typhoid fever can be done by utilizing different samples, targets and methods. Diagnosis of 
typhoid fever is done when an isolate is serotyped as Typhi whether from blood, bone 
marrow, stool or other specific anatomical lesions. However, a major setback from this, is 
that it requires proper laboratories equipment with the right tools and technical staff which 
are not readily available in most developing countries. Points of care detection (POC) such 
as antibody- and antigen- detection kits are widely used but however it remains insensitive 
enough. Antigen detection kits are useful for early diagnosis such as first week of infection. 
Antigen detection kits have sensitivities depending on the number of bacteria presents in the 
test sample. While for antibody detection kits, it depends on the production of antibody 
against S. Typhi in the subject human body. Since S. Typhi bacteria had a long incubation 
period, an antibody detection test is more feasible. Antibody kit can be used to detect IgM 
antibodies which peak at 7-10 days of infection and IgG at 14-21 days of infection. Also 
there are nucleic acid detection methods but concerns and high cost for nucleic acid 
amplification kits makes it not feasible. Each of the diagnosis method of typhoid fever will 
be discussed individually. 
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2.4.1 Clinical Syndrome 
Presence of clinical sign and symptoms of typhoid fever and a history of travel to developing 
countries provide a clue to doctors to diagnose the disease. The incubation period of typhoid 
infection is 6 to 30 days depending on the infecting dose of bacilli and host immune response. 
The onset of illness is insidious, with gradually increasing fatigue and a fever that increases 
daily from low-grade to as high as 38
o
C to 40
o
C by the third to fourth day of illness. Often 
there is a sign on hepato-splenomegaly. A transient, macular rash of rose-colored spots can 
occasionally be seen on the trunk. Fever is commonly lowest in the morning, reaching a peak 
in late afternoon or evening. This symptom is often confused with malaria. If untreated, the 
disease can persist for a month. Serious complication occurs 2 – 3 weeks after onset of 
illness, with complication like intestinal hemorrhage or perforation which can be life 
threatening. Healthcare workers will rely on this clinical judgment of the disease and without 
proper diagnostic tests cannot differentiate S. Typhi from S. Paratyphi A and other febrile 
illness, such as dengue, leptospirosis, rickettsia and malaria (Maskey et al., 2006). Generally, 
healthcare workers prescribe a broad-spectrum anti-microbial agent to target the bacterium 
based on the observation on the infection. Due to this, inappropriate antimicrobial treatment 
might be administrated, which will exert selective pressure on S. Typhi and other gut 
pathogen potentially causing an increase in antimicrobial-resistance (Chau et al., 2007). 
 
2.4.2 Microbiology Culture Method 
The gold standard for diagnosing typhoid fever is through isolation of S. Typhi from blood, 
bone marrow, rose spots or other sterile sites. A benefit of culture method is that it allows 
bacterial isolation, which confirms clinical diagnosis and allows antimicrobial-susceptibility 
testing so that proper therapy can be administrated. The standard method for diagnosis of 
typhoid fever is by blood culture method. Blood culture method had a 40 to 70% positive 
detection of S. Typhi bacteria in the blood of the patients. (Wain et al., 2008). Several 
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reasons for this low sensitivity are that to the volume of blood drawn from the patients. 
Volume of blood taken from adults and school children needs to be higher compare to 
childrens between 12 to 36 months old. The reason for this is because children have higher 
levels of bacteria in their blood compared to adults (WHO, 2003). The quantity of bacteria in 
bloodstream is higher in the first seven days of infection compared with later weeks. Also if 
patients had pre-antimicrobial treatment, the quantity of bacteria viability will be lower the 
in bloodstream. Another factor contributing to failure of isolating viable bacteria is due to 
limited culture media in these laboratories. Culture media such as Oxgall media, tryptone 
soya broth or brain-heart infusion broth or bespoke media used for automated blood culture 
systems such as BACTEC® and BactAlert® are suitable to recover the bacteria.  Generally 5 
ml of fresh blood from the patient are inoculated with 45 ml of brain heart infusion borth or 
tryptic soy broth and incubated overnight at 37
o
C. Blood agar (horse or sheep blood) is used 
for subculturing as S. Typhi produce white colonies on blood agar. MacConkey agar can be 
used as a substitute for blood agar as MacConkey agar allows the growth of only bile-
tolerant bacteria and inhibit the growth of many Gram-positive contaminants and even E. 
coli. 
 
The diagnosis of typhoid fever by bone marrow culture, gives a positive detection rate of up 
to 90% of cases even when the patients have been treated with antibiotics (Farooqui et al., 
1991).This is because the amount of bacteria in the bone marrow is ten times higher than in 
blood. However it is challenging to obtain the sample as this method is invasive, difficult to 
perform, requires equipment and trained laboratory personnel found primarily in developed 
countries. Bone marrow is important for diagnosis of patients who have previously 
undergone treatment, who have history of illness and who had blood culture negative.  
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Stool or rectal swab culture is another culture method for S. Typhi isolation which is less 
invasive. Isolation of S. Typhi from stool sample may indicate merely that the patient is 
infected with S. Typhi but cannot differentiate between acute or carrier status. S. Typhi can 
be isolated from stool samples after 2 weeks and after 3 weeks for urine samples after the 
acute infection. Stool culture method diagnostic rate is less than 50% but it can be improved 
to 98% when combined with blood culture, rectal swabs, bone marrow and duodenal strings 
(Hoffman et al., 1984; Crum, 2003).  
 
The major downside of using culture method is it requires about 2 to 7 days to obtain the 
results. Although culture method is specific, it lacks sensitivity and speed. As a result, 
diagnosis might be delayed and can influence the decision of health care workers in 
outpatient clinics on the management and antimicrobial selection at the time of consultation. 
In addition, most developing countries lack proper equipment and personnel to do the 
culturing method.  
 
Characteristics of Salmonella Colonies Grown on Agar Plates 
Blood agar 
S. Typhi grows as non-haemolytic smooth white colonies on blood agar. 
MacConkey agar 
S. Typhi will produce lactose non-fermenting smooth colonies on MacConkey agar. 
Salmonella-Shigella (SS) agar 
S. Typhi produce lactose non-fermenting colonies with black centres on SS agar. 
Desoxycholate agar 
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S. Typhi produce lactose non-fermenting colonies with black centres on desoxycholate agar. 
Xylose-lysine-desoxycholate agar 
S. Typhi produce transparent red colonies with black centres on xylose-desoxycholate agar. 
Hektoen enteric agar 
S. Typhi produce transparent green colonies with black centres on hektoen enteric agar. 
Bismuth sulfite agar 
S. Typhi produce black colonies on bismuth sulfite agar. 
Commonly used biochemical tests used for the identification of Salmonella and their results 
are as follows (Figure 2.4); 
Organism Klinger’s iron agar Motility, Indol, Urea Citrate 
Slant Butt H2S Gas Motility Indol Urea  
S. Typhi Alk Acid Wk+ - + - - - 
S. Paratyphi A Alk Acid - + + - - - 
Nontyphoidal 
Salmonella or 
Salmonella Paratyphi B 
or C 
Alk Acid Wk+ + + - - V 
E. coli Acid Acid - + + + - - 
Klebsiella spp. Acid Acid - ++ - V + + 
Citrobacter spp. V Acid +++ + + V - + 
Proteus spp. Alk Acid + + + V ++ V 
 
Figure 2.4: Biochemical tests for the identification of Salmonella 
Alk = alkaline, Wk = weak, V = variable result, + = positive, - = negative 
Production of acid will turn the agar yellow. For the slant agar this means lactose 
fermentation and butt this means glucose fermentation. 
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2.4.3 Serological Diagnosis 
2.4.3(a) Widal Agglutination Test 
Widal test is a serological test based on the principal of bacterial cell agglutination for 
diagnosis of typhoid fever. It measures agglutinating antibodies in infected patients sera 
against the O (somatic) antigens resident within the cell wall structure and H (flagella) 
antigens from the bacterial flagellae and the Vi (virulence) antigens originating from the 
capsule surrounding the cell wall. The O and H antigens form the basis upon which the 
Salmonella genus is divided into species level. S. Typhi has the O-9, O-12 and d-H antigens. 
Patients suffering from enteric fever would possess antibodies in their sera which can react 
and agglutinate serial doubling dilutions of killed, Salmonella antigens in the agglutination 
test. If homologous antibody is present in a patient‟s serum, it will react with the antigen in 
the reagent and gives visible clumping on the test card. Antibody level are considered 
significant at dilution of greater than or equal to 1 : 160, but different cut-off titers was also 
reported (Bakr et al., 2011). Serum agglutinins increase during the second week (day 6 – 8) 
of the infection for the O-antigen, and the third week (day 10 – 12) for H-antigen (Kundu et 
al., 2006). If the blood sample is collected too early during the infection, false negative 
results might be obtained. The accepted criterion diagnosis of typhoid fever using Widal test 
is a fourfold rise in the agglutinin titer of the paired sera against the O antigens of S. Typhi.   
 
Widal test is cheap and easy to use and it only requires a few minutes to complete the test. In 
endemic areas where proper equipment for bacteria culture is lacking or limited, the Widal 
test is widely used to differentiate enteric infection from other illnesses. However the test has 
some major limitation. It lacks standardization of reagents and inappropriate interpretations 
of results occur.  Widal test has poor specificity and cutoff titer that differs according to 
endemicity of the disease. Causes of negative Widal test can be due to patient not infected by 
S. Typhi, patient in the carrier state, inadequate inoculum of the bacterial antigen in host to 
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induce antibody response, technical difficulty or errors in the performance of the test, patient 
had previous antibiotic treatment and variability in the preparation of the antigens. However 
the Widal test is also prone to false negative results where a defect in antibody production or 
infection can have an inhibitory effect on agglutinin production. While for positive result for 
Widal test can be interpreted as the patient being tested positive for typhoid fever, patient 
had previous immunization with Salmonella antigen, cross-reaction with non-typhoidal 
Salmonella, variability and poorly standardized commercial antigen preparation, patients 
infected with other enterobacteriaceae or had malaria or dengue (Olopoenia and King, 2000). 
With sensitivity of 64% and 76% specificity, the used of Widal test were not encouraged 
(Olsen et al., 2004).  
 
2.4.3(b) IDL Tubex® Test 
The IDL Tubex® test is an antibody-detection kit for S. Typhi. This kit is a simple and rapid 
test which is based on the inhibition of binding between two types of reagent particles. First 
reagent is the colored latex particles which are coated with a monoclonal antibody specific 
for O9 and second reagent are the magnetic particles coated with S. Typhi 
lipopolysaccharide. The S. Typhi-specific antibodies from sera of suspected S. Typhi are 
detected by their ability to inhibit the binding between colored indicator particles that are 
coated with a monoclonal antibody specific for the S. Typhi O9 LPS antigen, and magnetic 
particles that are coated with S. Typhi LPS. Results can be obtained after 5 minutes by 
comparing the color of the supernatant with the color standards provided by the 
manufacturer. A Tubex® score of 4 indicate the lowest limit for a positive reaction 
indicating the detection of 31 micrograms of the anti-Salmonella antibody per milliliter (Lim 
et al., 1998). A positive Tubex® test suggests Salmonella infection and the test is not known 
to cross react with S. Paratyphi A. Tubex® can detect IgM antibodies and is useful in 
diagnosis of acute patients. Tubex® sensitivity and specificity finding was 78% and 89% 
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respectively (Olsen et al., 2004). Disadvantages of Tubex® are its difficulty in obtaining 
results from haemolysed samples as it uses a agglutination reaction and Tubex® may 
potentially produce a false positive in a patient with recent S. enterica serotype Enteritidis 
infection (Oracz et al., 2003).  
 
2.4.3(c) Typhidot® and Typhidot-M® 
Typhidot test detects specific IgM and IgG antibodies against the outer membrane protein 
(OMP) of the S. Typhi (Ismail et al., 1991b; Choo et al., 1999). The OMP used in 
Typhidot® has a molecular weight of 50 kDa and is a specific protein on the outer 
membrane of S. Typhi (Ismail et al., 1991a). The 50 kDa antigen was found to be antigenic 
as well as specific for S. Typhi as it only reacted immunologically with typhoid sera (Ismail 
et al., 1991b). The 50 kDa demonstrated a sensitivity of greater than 90% and specificity of 
75% (Choo et al., 1994). Typhidot-M had been evaluated in clinical settings and 
demonstrated its simplicity, speed (1 to 3 hours), specificity (75%), sensitivity (95%), 
economy, early diagnosis and with high negative and positive predictive values (Choo et al., 
1994).  The detection of IgM by Typhidot® indicates that the patient has acute typhoid fever 
in the early phase of infection. While detection of both IgG and IgM indicate that the patient 
has acute typhoid fever in the middle phase of infection. In endemic regions where the 
numbers of cases of typhoid fever are high, detection of specific IgG will increase as the IgG 
antibodies can persist up to 2 years after typhoid infection. As this is due to the detection of 
specific IgG could not differentiate between acute and convalescent patients. In addition to 
this, false positive results might arise due to re-infection from previously infection. Re-
infection have a “boosting” effect of IgG over IgM which causes “masking” of IgM due to 
high concentration of IgG. Modification was done to the original Typhidot® test by 
inactivating total IgG in the serum sample to uncover IgM in order to increase the diagnostic 
accuracy of the Typhidot-M® test in such conditions. A comparison of culture, widal, 
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Typhidot® and Typhidot-M in clinical settings revealed that the Typhidot® and Typhidot-
M® test both performed better than Widal test and culture method (Ismail et al., 1998).  A 
meta-analysis of Typhidot was performed with limited data and demonstrated that the 
Typhidot® kit had high variability in the sensitivity and specificity with estimates ranging 
from 56% to 84% and 31% to 97%, respectively (Thriemer et al., 2013). Variation in the 
sensitivity and specificity could be due to the preparation of the 50 kDa protein.   
Table 2.1: Typhidot Reference Studies 
Study / published year, reference Total no. of 
samples 
Sensitivity 
(%) 
Specificity 
(%) 
Membrebe FA, Chua / 1998 
 
Jesudasan MV, Sivakumar S / 2006 
 
Begum Z, Hossain MA et al. / 2009 
 
Choo KE, Oppenheimer SJ et al. / 1994 
 
Choo KE, Davis TME et al. / 1999 
 
Narayanappa D, Sripathi R et al. / 2010 
 
Krishna S, Desai S et al. / 2011 
185 
 
563 
 
100 
 
109 
 
134 
 
105 
 
186 
72.0 
 
92.3 
 
92.8 
 
95.0 
 
93.1 
 
92.6 
 
100 
52.0 
 
98.8 
 
90.0 
 
75.0 
 
80.6 
 
37.5 
 
95.5 
 
2.4.3(d) IgM dipstick 
IgM dipstick test in the market designed to diagnose typhoid fever by detection of S. Typhi-
specific IgM antibodies in serum or whole blood samples towards S. Typhi LPS antigen. 
IgM dipstick is one of the point-of-care (POC) test which uses lateral flow assay (LFA) 
technology.  The components of this test consist of a dipstick, a detection reagent, buffer for 
detection reagent, buffer to wet the test strip and tubes. One advantage of the dipstick test is 
that the components are stable and have a shelf life of two years if stored at temperature 
range 4 to 25
o
C.  Color development is based on gold nanoparticles conjugated to rabbit anti-
human IgM antibody which gives the red line when bind on the test and control line on the 
membrane. In the dipstick test, the test line is stripped with the S. Typhi LPS antigen while 
the control line is stripped with anti-human IgM antibodies. Test is performed by incubation 
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of the wetted test strip with diluted serum and detection reagent for a period of 3 hour at 
room temperature. After incubation the strip was time and rinsed with water after the 
incubation. Result is interpreted by visual inspection of the test strip for staining of the 
antigen and control lines. The test is positive when both test and control lines are visible. 
Studies show that the dipstick yielded a sensitivity of 65% to 77% and specificity of 95% to 
100% (WHO, 2003). Several factors influence the results of the dipstick; among them are 
time of sample collection and the use of antibiotics before consultation and sample collection. 
 
LFA have been increasingly widely used in clinical analysis. The used of Lateral flow assay 
(LFA) as POC test had been rapidly growing for qualitative and quantitative analyses. The 
reasons for rapid growth of LFA is that LFA is rapid and only one step analysis, low 
operational cost, high specificity and sensitivity, long term stability and portability of the 
device are some of the advantages of LFA. LFA are simple devices to detect the presence or 
absence of a target analyte in the sample by using capillary technology. In addition to that, 
LFA does not require special equipment and trained personnel. 
 
The lateral flow assays are built on a few components. It consists of the membrane or 
analytical region, the absorbent pad, sample pad and conjugate pad. The analytical region 
consists of the test line and control line. This region is where the target analyte binds to the 
antibody or antigen on test line and result in a positive detection. The membrane is the most 
important material used in a LFA. When a test is performed, the membrane must allow the 
conjugate and sample from the conjugate pad to flow consistently toward the test line and 
control line and allow the reaction or binding to happen, and finally allow the excess fluid to 
flow out without binding. Commonly used membrane matrix for LFA is nitrocellulose, 
which can have characteristics such as high protein-binding capacity, relative ease of 
handling and low cost. However, the downside of using nitrocellulose membrane is that it 
23 
 
may have imperfect reproducibility of performance between manufacturer lots and variable 
environmental conditions such as temperature and humidity. The proper performance of the 
LFA is based upon protein-binding capacity of the membrane, its interaction with protein 
and the kinetics of the protein-binding processes. Electrostatic, hydrogen and hydrophobic 
forces are involved in the binding of protein to the nitrocellulose membrane. One important 
criterion for choosing the right membrane is the capillary flow rate as there is a direct 
correlation between the flow rate and the sensitivity of the test. A slow rate membrane will 
provide higher sensitivity compared with a fast rate membrane.  
 
Absorbent pads function as a “sink” at the end of the strip. Absorbent pad capacity to hold 
liquid also plays an important role in the quality of the results since with insufficient capacity 
will cause the test sample to flow back in the membrane and could raise the background 
noise or possibly cause false positives. A large capacity pad also helps to maintain a constant 
flow rate of the liquid over the membrane. 
 
The sample pad could be made of cellulose and/ or glass fiber. The test sample is first 
applied on this pad at the beginning of the assay to transport the test sample to other 
components of the test strip. The sample pad act as a pretreatment before the samples moves 
to and reacts with the test line. This pretreatment functions such as a separation of sample 
components, removal of interfering components, adjustment of pH and prevent non-specific 
binding of the conjugate with the analyte downstream. 
 
The function of the conjugate pad is to hold the detector particles in a dry form so that they 
are functionally stable until resuspended by the buffers.  After the sample is applied on the 
sample pad, it moves up towards the conjugate pad. On the conjugate pad the detector 
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particles need to be released rapidly. The conjugate pad needs to have a consistent flow rate 
as it may cause uneven signal development at the test and control lines and affect the 
sensitivity of the assay. Conjugate pad are made from materials such as glass fiber, cellulose 
and polyesters.  
 
Lateral flow assay can be based on two formats, the sandwich format and the competitive 
format. In a typical sandwich format, a label is immobilized on the conjugate pad. The label 
could be either secondary antibody which can be transported by capillary action of a buffer 
solution. The test line contains primary antibody against target analyte and control line 
consist of an antibody against the labeled conjugated antibody. To perform a sandwich 
lateral flow assay, the test sample (containing analyte) is applied on the sample pad and it 
will flow by capillary action to the other side of the strip. At the conjugate pad, target analyte 
bind with the labeled conjugated antibody, resulting in a labeled antibody conjugate/analyte 
complex. The complex continues to move up on the nitrocellulose membrane and when it 
reaches the test line, the complex and analyte binds to the primary antibody. Thus the analyte 
is sandwich between the two antibodies. Excess label will be captured on the control line and 
the absorbent pad. Formation of a colored line at the control line indicating excess reagent is 
used and ensures the strip works properly.  
 
In this study LFA was chosen as one of the assay to be used with the selected diagnostic 
marker for the diagnosis of typhoid fever. The lateral flow assay was performed on a half-
dipstick format. Half-dipstick formats are the same as the sandwich format except for the 
conjugate release pad which contains the gold-labelled antibody. In this format, the dipstick 
is first dipped into human sera and washed by dipping into washing buffer before dipped into 
the gold-labelled conjugates.  
 
